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Abstract
Background: Rapid diagnostic tests (RDTs) are the current complement to microscopy for ensuring prompt malaria
treatment. We determined the performance of three candidate RDTs (Paracheck™-Pf, SD Bioline malaria Ag-Pf and
SD Bioline malaria Ag-Pf/pan) for rapid diagnosis of malaria in the Central African Republic.
Methods: Blood samples from consecutive febrile patients who attended for laboratory analysis of malaria at the
three main health centres of Bangui were screened by microscopy and the RDTs. Two reference standards were used to
assess the performance of the RDTs: microscopy and, a combination of microscopy plus nested PCR for slides reported
as negative, on the assumption that negative results by microscopy were due to sub-patent parasitaemia.
Results: We analysed 436 samples. Using the combined reference standard of microscopy + PCR, the sensitivity of
Paracheck™-Pf was 85.7% (95% CI, 80.8–89.8%), that of SD Bioline Ag-Pf was 85.4% (95% CI, 80.5–90.7%), and that of SD
Bioline Ag-Pf/pan was 88.2% (95% CI, 83.2–92.0%). The tests performed less well in cases of low parasitaemia; however,
the sensitivity was > 95% at > 500 parasites/μl.
Conclusions: Overall, SD Bioline malaria Ag-Pf and SD Bioline malaria Ag-Pf/pan performed slightly better than
Paracheck™-Pf. Use of RDTs with reinforced microscopy practice and laboratory quality assurance should improve
malaria treatment in the Central African Republic.
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Background
In countries in sub-Saharan Africa, malaria management
is frequently based on clinical criteria, leading to overuse
of antimalarial agents [1,2]. After the 1990s, a rapid
increase in resistance to first-line therapy was observed,
with a consequent decrease in the efficacy of chloroquine
[3] and its replacement by sulfadoxine-pyrimethamine
[4,5]. Subsequently, effective but more expensive artemisi-
nin combination treatments were introduced for first-line
treatment [6]. These new therapies should be targeted in
order to avoid overuse of antimalarial drugs, which can
lead to the selection of drug-resistant parasites [7].
The World Health Organization (WHO) recommends
parasitological confirmation for all patients suspected of
having malaria before starting treatment. This recom-
mendation includes high-quality microscopy or, when
that is not available, use of easy-to-use rapid diagnostic
tests (RDTs) [8]. Panel studies have been conducted to
compare the performance of commercially available
RDTs [9]. Although these studies provide selection
criteria, field evaluations are essential to obtain operational
data [10-15], as the heterogeneous performance of these
tests depends on local factors, such as deletions or muta-
tions in the PfHRP-2 gene [16-21], the prozone effect [22],
cross-reactivity with human autoantibodies [23,24] and the
presence of other infectious diseases [25]. Local data are* Correspondence: amanirak@yahoo.fr
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therefore required to select suitable RDTs before they are
used [16,26-28].
A recent multi-centre study assessing global sequence
variation in PfHRP-2 and −3 found wide variation in
PfHRP-2 sequences in samples from the Central African
Republic. The authors speculated that this might reduce
the sensitivity of RDTs for detecting malaria in people
with very low parasite density [29]. In this country, the
quality of microscopy in the public health sector is poor,
and presumptive treatment of malaria is still wide-
spread [30]. The Ministry of Health has selected the
RDTs Paracheck™-Pf, SD Bioline malaria Ag-Pf and SD
Bioline malaria Ag-Pf/pan as candidates on the basis of
panel studies [9]. The objective of the study reported here
was to evaluate the performance of these tests in the field.
Methods
Study area and design
This cross-sectional study was conducted in August
2011 in Bangui, capital of the Central African Republic,
in the Hospital de l’Amitié, the Complexe Pediatrique
and the Institut Pasteur of Bangui. Bangui is located
beside the Oubangui River, north of the Democratic
Republic of the Congo (geographical coordinates 7.00 N,
21.00 E). The climate is tropical, and rainfall peaks be-
tween April and November. The average temperature
varies from 19°C to 32°C. The main malaria parasite is
Plasmodium falciparum, and malaria transmission occurs
throughout the year, with peaks at the beginning and the
end of the rainy season, although no data are available on
the intensity of transmission. Malaria accounts for more
than 40% of morbidity in the country (Central African
Republic Ministry of Health, 2010 annual report, un-
published data).
The Hospital de l’Amitié and the Complexe Pédiatrique
are tertiary referral public health centres equipped with
laboratories where thin and thick smears are analysed. The
Institut Pasteur of Bangui is a private centre (International
Network of Instituts Pasteur) for biomedical research, in
which laboratory diagnosis for malaria is performed for
patients referred by clinicians at health centres where this
test is not available.
We analysed the performance of three RDTs:
Paracheck™-Pf, SD Bioline malaria Ag-Pf and SD Bioline
malaria Ag-Pf and /pan (Standard Diagnostics Ref 05FK60,
Inc; Suwon City, Republic of Korea). SD Bioline Malaria
Ag Pf and Paracheck™-Pf contain antibodies against
P. falciparum-specific histidine-rich protein type 2
(PfHRP2), while Bioline Malaria Ag Pf/Pan contains anti-
bodies targeting both PfHRP2 and lactate dehydrogenase
specific to P. falciparum and other Plasmodium species
(P. vivax, P. ovale and P. malariae). Blood samples from
people attending each study centre for laboratory analysis
were tested for the presence or absence of malaria
parasites by microscopy and the RDTs. Samples from
patients with negative microscopy (regardless of RDT
result) were tested P. falciparum by nested PCR, on the
assumption that false-positive results with RDTs are
due to sub-patent parasitaemia [31].
Patient recruitment
Consecutive patients of all ages presenting at each study
site were approached by the study technician for recruit-
ment. Each patient’s medical card was checked, and
those with a request for smear analysis were considered
eligible if they were febrile (axillary temperature ≥ 37.5°C)
or had a history of fever in the previous 24 h. They were
included in the study if they gave written consent; for
patients aged ≤ 18 years, informed consent was provided
by a parent or guardian.
Ethical approval
This project was reviewed and approved by the ethical
committee of the University of Bangui. The Central
African Republic Health Ministry also gave approval for
this study.
Sample size estimation
For an estimated annual malaria rate in Bangui of 40%
(Central African Republic Ministry of Health, 2010 an-
nual report, unpublished data), an expected sensitivity of
Bioline RDTs of 95% [26] and a sensitivity set at ± 2.5%,
a sample size of 421 patients was estimated.
Selection of technicians
In each study centre, the laboratory team consisted of
three technicians with university training, all of whom
had been re-trained for diagnosing malaria in the labora-
tory by standard operational procedures [32]. The tech-
nicians were also trained to perform and read the
Paracheck™-Pf, SD Bioline malaria Ag-Pf and SD Bioline
malaria Ag-Pf and /pan tests. At the Institut Pasteur, a
fourth laboratory technician was designated to analyse
all discrepant slides and to perform PCR.
Malaria diagnosis
Finger-prick blood samples were obtained for slides and
for testing with the RDTs. Blood smears were air-dried,
stained with 4% Giemsa and analysed under a light
microscope (× 100 oil immersion) to detect asexual
forms of P. falciparum. Parasite density was determined
as the number of parasites per 200 leukocytes on the
assumption of an average leukocyte count of 8000/μl of
blood. A result was considered negative if no parasites
were detected per 200 leukocytes. Each slide was read
independently by two study technicians. In the case of a
discrepant qualitative result (negative or positive), a third
reading was done by the designated technician at the
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Institut Pasteur. All the laboratory technicians were
blinded to the RDT results. The results of both micros-
copy and the RDTs were reported to the clinicians, who
were advised to treat the patient for malaria if the results
of these two analyses were discrepant.
The RDTs were performed by the third technician at
the study centre following the manufacturer’s instructions.
For patients with negative microscopy, three drops of
blood were collected on a piece of filter paper (Whatman®).
The blood spots were air-dried and stored at 4°C in indi-
vidual sterile plastic bags for PCR analysis.
Parasite DNA extraction and PCR assays were per-
formed at the Institut Pasteur. The blood-impregnated
filter paper piece was washed with distilled water and
placed directly in a PCR tube containing the PCR reac-
tion components. Genomic DNA was determined in an
assay based on nested PCR for Plasmodium DNA [33].
Statistical analysis
Data were entered onto Excel spreadsheets and analysed
with MedCalc®software (MedCalc Software, Acacialaan
22, B-8400 Ostend, Belgium).
The first step of our analysis was to determine the per-
formance of the RDTs according to the falciparum density
in samples found positive by microscopy. Density was cate-
gorized as ≤ 100, 101–200, 201–500, 501–1000, 1001–5000,
5001–50 000 and > 50 000 parasites/μl. RDT results were
compared (paired proportions) with the McNemar test, at
a level of significance (P) of 0.05.
The second step was to estimate the performance of
the RDTs against the combined results of microscopy and
nested PCR, expressed as true-positive (TP), true-negative
(TN), false-positive (FP) or false negative (FN). The
formulas used to calculate performance were TP/TP + FN
for sensitivity, TN/TN + FP for specificity, TP/TP + FP
for positive predictive value (PPV) and TN/TN+ FN for
negative predictive value (NPV). The results were inter-
preted with 95% confidence intervals (CIs). At baseline, the
results of the comparison between the RDTs and micros-
copy were expressed as TP1, TN1, FP1 or FN1. Then, the
analysis took onto account the results of PCR performed
on samples that were negative by microscopy (classified as
FP1 or TN1 in the RDTs). According to the PCR results,
the results of the RDTs were designated as TP2 if PCR was
positive in FP1, FP2 if PCR was negative in FP1, FN2 if PCR
was positive in TN1 and TN2 if PCR was negative in TN1.
Combination of the results of the RDTs for samples posi-
tive by microscopy and of PCR for samples negative
by microscopy gave the values TP =TP1 + TP2, TN =TN2,
FP = FP2 and FN= FN1 + FN2, which were used to calculate
the performance of the RDTs.
Results
A total of 437 patients were recruited for this study
between 8 and 22 August 2011. Microscopic analysis
showed that 53.8% (235/437) of the blood slides were
positive for P. falciparum. In 234/235 (99.6%) cases of in-
fection, P. falciparum was the only parasite species identi-
fied. One infected individual had a P. ovale mono-infection
(detected by SD Bioline malaria Ag-Pf/pan and confirmed
by nested PCR) and was hence excluded from the study,
which was confined to detection of falciparum malaria.
The RDTs gave positive results in 52.3% (228/436) of
cases with Paracheck™-Pf, 57.8% (252/436) with SD Bioline
malaria Ag-Pf and 58.0% (253/436) with SD Bioline malaria
Ag-Pf/pan.
Comparison of the results of the RDTs with those of
microscopy showed concordant positive results in 85.9%
(201/234) of cases with Paracheck™-Pf, 92.3% (216/234)
with SD Bioline malaria Ag-Pf and 92.3% (216/234) with
Figure 1 Rapid diagnostic test performance results by parasitaemia level.
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SD Bioline malaria Ag-Pf/pan. Of the samples that were
negative by microscopy, 13.4% (27/202) were found to
be positive with Paracheck™-Pf, 17.8% (36/202) with SD
Bioline malaria Ag-Pf and 18.8% (38/202) with SD Bioline
malaria Ag-Pf/pan.
The proportion of positive results with each of the RDTs
increased with parasitaemia. For a parasitaemia ≤ 100
parasites/μl, the proportions were 56.5% with Paracheck™-
Pf and 69.6% with SD Bioline malaria Ag-Pf and SD Bioline
malaria Ag-Pf/pan. For a parasitaemia < 501 parasites/μl,
the proportion of positive results with Paracheck™-Pf was
significantly lower than with the Bioline kits (p = 0.04)
(Figure 1). The sensitivity of the RDTs correlated positively
with parasitaemia, with values < 70% when the parasit-
aemia was < 100 parasites/μl. The sensitivity of the SD
Bioline devices increased to > 80% when the parasitaemia
was 101–200 parasites/μl, whereas the sensitivity of
Paracheck™-Pf remained at 63.4%. The sensitivity of all
three tests increased substantially (> 95%) at parasite
counts > 500 parasites/μl (Table 1). Negative results were
found with all three RDTs in 18 blood samples with
parasitaemia ranging from 40 to 400 parasites/μl.
PCR assays detected 11 false-negative results (11/202
or 5.4%) by microscopy and 7 false-negative results (7/202
or 4.2%) by both microscopy and the RDTs. Overall, the
combined results of microscopy and PCR showed a sensi-
tivity of 85.7% for Paracheck™-Pf, 85.4% for SD Bioline
malaria Ag-Pf and 88.2% for SD Bioline Ag-Pf/Pan. The
specificity was 86.0% for Paracheck™-Pf, 86.3% for SD
Bioline malaria Ag-Pf and 80.4% for SD Bioline malaria
Ag-Pf/pan.
The overall sensitivities, specificities, NPV and PPV for
the three RDTs, evaluated against microscopy and mi-
croscopy and PCR are detailed in Table 2.
Discussion
The sensitivity and specificity of the tested RDTs found in
this study appear to fall within the ranges quoted in other
studies, which reported a sensitivity of Paracheck™-Pf of
82.9–100% and a specificity of 56.0–96.4% [34-42] and a
sensitivity of the SD Bioline tests of 83.3–100% and a spe-
cificity of 86.8–98.9% [43-45]. WHO standards for RDT
procurement for high-transmission areas include a rec-
ommendation that the panel detection scores against
P. falciparum samples be at least 75% at 200 parasites/μl,
although discrepancies between these scores and clinical
sensitivity are limitations of these tests [46,47].
In this study, some blood samples that were negative
by microscopic examination gave negative results in all
three RDTs, while some gave positive results in all RDTs.
Factors that affect the sensitivity and specificity of RDTs,
such as low parasitaemia, are particular challenges for
malaria diagnosis with these new devices. We found that
a parasitaemia between 40 and 400 parasites/μl in blood
samples with positive results by microscopy gave negative
results in all three RDTs. This finding corroborates those
Table 1 Sensitivity of rapid diagnostic tests by parasite density (microscopy)
Parasites/μl (microscopy) No. of analyses SD Bioline AgPf SD Bioline AgPf/Pan Paracheck™-Pf
Sensitivity (%) 95% CI Sensitivity (%) 95% CI Sensitivity (%) 95% CI
≤ 100 23 69.6 [47.1–86.8] 69.6 [50.8– 88.4] 56.5 [34.5–76.8]
101–200 41 80.5 [65.1–91.2] 80.9 [68.9– 92.9] 63.4 [46.9–77.9]
201–500 28 89.3 [71.8–97.7] 89.3 [71.8–97.7] 82.1 [63.1–93.9]
501–1000 40 100 – 100 – 100 –
1001–5000 34 97.1 [85.1–99.9] 100 – 91.2 [76.3–98.1]
5001–50 000 58 100 – 100 – 98.3 [90.8–99.9]
> 50 000 11 100 – 100 – 100 –
Table 2 Overall sensitivity, specificity and negative and positive predictive value of the three RDTs evaluated against
microscopy, and microscopy and PCR
Reference Sensitivity Specificity Positive predictive value Negative predictive value
[95% CI] [95% CI] [95% CI] [95% CI]
Paracheck™-Pf Microscopy 85.9 [80.8-90.1] 86.6 [81.1-91.0] 88.2 [83.2-92.1] 84.1 [78.4-88.8]
Microscopy and PCR 85.7 [80.8–89.8] 86.0 [80.1–90.6] 89.3 [84.7-92.9] 81.5 [75.4-86.7]
SD Bioline AgPf Microscopy 92.3 [88.1-95.4] 82.2 [76.2-87.2] 85.7 [80.8-89.8] 90.2 [85.0-94.1]
Microscopy and PCR 85.4 [80.5–90.7] 86.3 [80.5–9.7] 89.7 [85.1-93.2] 81.0 [74.8-86.3]
SD Bioline AgPf/Pan Microscopy 92.3 [88.1-95.4] 81.2 [81.1-91.0] 85.0 [80.0-89.2] 90.1 [84.8-94.0]
Microscopy and PCR 88.2 [83.2–92.0%] 80.4 [74.3–85.5] 83.1 [77.7-87.6] 86.1 [80.5-90.7]
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of other studies [48-52], which reported false-negative re-
sults with RDTs at a parasitaemia < 500 parasites/μl. It has
been suggested that lower levels of HRP2 during a malaria
episode with low parasitaemia might not be detected by
RDTs [53] because malaria antigenaemia depends on the
parasite biomass in the patient’s body during an acute
episode [54].
Furthermore, deletions or mutations in the HRP 2
gene may reduce the sensitivity of these RDTs [16-21]. It
has also been speculated that the variation in PfHRP2 se-
quences in samples from the Central African Republic
might reduced the sensitivity of RDTs for detecting mal-
aria at very low parasite density [29]. Other factors, such
as the ‘prozone effect’ for Paracheck™-Pf at high parasite
densities [55] and the presence of anti-HRP 2 in humans
[22], might explain why some tests give negative results
despite significant parasitaemia.
Cases incorrectly identified as positive by the RDTs
might be due to the persistence of PfHRP2 from previ-
ous malaria infections [56], cross-reactivity with human
autoantibodies [23,24] or other infectious diseases [25].
This study has some limitations. First, PCR was per-
formed only on samples found negative by microscopy.
It might be considered incorrect to use a different “gold
standard” for slides found to be positive and those found
to be negative by microscopy, by using PCR only for
slides found negative by microscopy. However, the risk
for false-positive microscopy results was considered low,
as the slides were read independently by two experienced
technicians. The fact that the microscopists counted
only 200 negative leukocytes before declaring a slide as
negative might have decreased the sensitivity of micro-
scopic detection in this study. PCR is a useful gold stand-
ard because it is highly sensitive, can detect cases with low
parasitaemia that are missed by other techniques and is
easily reproducible [57]. Nevertheless, it is very expensive
and time- and labour-consuming and is therefore used
only to confirm the accuracy of microscopy in cases of
sub-patent parasitaemia [58] and to evaluate the perform-
ance of the RDTs or microscopy in determining malaria
prevalence [59].
Conclusions
This study showed that the performance of SD Bioline
malaria Ag-Pf and SD Bioline malaria Ag-Pf/pan was
better than that of Paracheck™-Pf. SD Bioline malaria
Ag-Pf/pan is the most useful test because it detects
other species of Plasmodium, even if they are less preva-
lent in the Central African Republic. Moreover, intro-
duction of these tests will indisputably help to identify
malaria cases in this area, where microscopy is still of
poor quality. Microscopy should nevertheless complement
RDTs for determining parasite density, and therefore
reinforcement of microscopy skills by ongoing training
of technicians and quality assurance of both RDTs and
microscopy should be considered priorities in national
malaria programmes. The results of this study also indicate
that RDTs should be evaluated in each new setting before
they are deployed, in view of possible variations in per-
formance in different populations.
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